Evidence map›Paper›PMID 31611532›Full record

ArticleInternal medicine (Tokyo, Japan)2020

Follicle-stimulating Hormone-secreting Pituitary Adenoma Accompanied by Painful Thyroiditis.

Masashi Ichijo, Kyoichiro Tsuchiya, Tsuyoshi Kasai, Naoko Inoshita, Haruko Yoshimoto, Shozo Yamada, Kenichiro Kitamura

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Masashi IchijoThird Department of Internal Medicine, University of Yamanashi, Japan.
Kyoichiro TsuchiyaThird Department of Internal Medicine, University of Yamanashi, Japan.
Tsuyoshi KasaiDepartment of Obstetrics and Gynecology, University of Yamanashi, Japan.
Naoko InoshitaDepartment of Pathology, Toranomon Hospital, Japan.
Haruko YoshimotoDepartment of Neurosurgery, Moriyama Neurological Center Hospital, Japan.
Shozo YamadaDepartment of Neurosurgery, Moriyama Neurological Center Hospital, Japan.
Kenichiro KitamuraThird Department of Internal Medicine, University of Yamanashi, Japan.
University of Yamanashi · JPToranomon Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 30-year-old woman with multiple ovarian cysts presented with high serum estradiol levels. She had a pituitary adenoma, but the follicle-stimulating hormone (FSH) concentration was within the normal range. The patient complained of neck pain and palpitations during the disease course, and laboratory results revealed thyrotoxicosis and a systemic inflammatory response with negative findings for anti-thyroid stimulating hormone (TSH) receptor antibody and positive findings for anti-thyroglobulin and anti-thyroid peroxidase antibodies. Prednisolone improved the symptoms and the thyroid function and was discontinued after two months. A histological examination of the pituitary tumor confirmed it to be FSH-producing pituitary adenoma, with subsequent normalization of the serum estradiol concentration.

Indexed as

AdenomaAdultAnti-Inflammatory AgentsFemaleFollicle Stimulating HormoneHumansJapanMagnetic Resonance ImagingPituitary NeoplasmsPrednisoloneThyroiditisTreatment OutcomeAnti-Inflammatory AgentsFollicle Stimulating HormonePrednisoloneFSH-secreting pituitary tumorHashimoto thyroiditis

Identifiers

PMID31611532
PMCPMC7056379
OpenAlexW2980889110

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.